Investors in iRobot Corporation (IRBT): Protect Your Rights – Contact Levi & Korsinsky Before September 5, 2025

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=159722&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Levi & Korsinsky Urges Neogen Corporation (NEOG) Shareholders to Act Before Lead Plaintiff Deadline September 16, 2025

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=159720&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine

METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series D financing round. The announcement was made at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial Park, a key hub for Beijing's life sciences sector. Financing Co-led by Beijing Medical and Health Industry Investment Fund

FTI Consulting Expands Forensic and Litigation Consulting Segment in Asia with Appointment of Martin Tupila as Senior Managing Director

(NYSE:FCN), SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the continued growth of its Forensic and Litigation Consulting segment in Asia with the appointment of Martin Tupila as a Senior Managing Director, based in Singapore. Mr. Tupila brings more than 20 years of experience in forensic accounting, financial investigations,

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / WHY: New York, N.Y., August 4, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE:HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the "Class Period"), of

FTI Consulting Expands Forensic and Litigation Consulting Segment in Asia with Appointment of Martin Tupila as Senior Managing Director

FTI Consulting Expands Forensic and Litigation Consulting Segment in Asia with Appointment of Martin Tupila as Senior Managing Director GlobeNewswire August 05, 2025 SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the continued growth of its Forensic and Litigation Consulting segment in Asia with the appointment of Martin Tupila

AT&T Data Incident Settlement Notice: $177 Million Settlement Fund for Eligible Claimants

If your Private Information was involved and/or if you were an Account Owner or Line User whose call records were involved in the AT&T Data Incidents, you may be eligible to receive benefits from a class action Settlement. The following statement is being issued by Kroll Settlement Administration regarding In Re: AT&T Inc. Customer Data

Lightium, MPI Corporation, and Axiomatic_AI Announce Strategic Partnership to Revolutionize Photonic Integrated Circuit (PIC) Device Testing with AI-Driven Solutions

Lightium AG, MPI Corporation, and Axiomatic_AI Inc. have entered into a Memorandum of Understanding (MoU) to jointly develop the world's first Intelligent, Autonomous, and Integrated Test Solution (IAITS) for photonic devices. This strategic collaboration aims to revolutionize the testing and qualification processes of photonic integrated circuit (PIC) devices by uniting state-of-the-art artificial intelligence, next-generation hardware,

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases,announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to initiate a Phase1 clinical trial of IBI3032,

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPL

(NASDAQ:REPL), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline in the securities

Scroll to Top